Activity of 8F4, a T cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo

por Sergeeva, Anna, He, Hong, Ruisaard, Kathryn, St. John, Lisa, Alatrash, Gheath, Clise-Dwyer, Karen, Li, Dan, Patenia, Rebecca, Hong, Richard, Sukhumalchandra, Pariya, You, M. James, Gagea, Mihai, Ma, Qing, Molldrem, Jeffrey J.
Publicado 2016

Delta-24-RGD Oncolytic Adenovirus Elicits Anti-Glioma Immunity in an Immunocompetent Mouse Model

por Jiang, Hong, Clise-Dwyer, Karen, Ruisaard, Kathryn E., Fan, Xuejun, Tian, Weihua, Gumin, Joy, Lamfers, Martine L., Kleijn, Anne, Lang, Frederick F., Yung, Wai-Kwan Alfred, Vence, Luis M., Gomez-Manzano, Candelaria, Fueyo, Juan
Publicado 2014

PR1 Peptide Vaccine Induces Specific Immunity With Clinical Responses In Myeloid Malignancies

por Qazilbash, Muzaffar H., Wieder, Eric, Thall, Peter F., Wang, Xuemei, Rios, Rosa, Lu, Sijie, Kanodia, Shreya, Ruisaard, Kathryn E., Giralt, Sergio A., Estey, Elihu H., Cortes, Jorge, Komanduri, Krishna V., Clise-Dwyer, Karen, Alatrash, Gheath, Ma, Qing, Champlin, Richard E., Molldrem, Jeffrey J.
Publicado 2016